The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis.
Paulus
H E
HE
University of California, Los Angeles, School of Medicine 90024.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004338:Drug Combinations; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000962:Antimalarials; D004338:Drug Combinations; D012460:Sulfasalazine; D006046:Gold; D003520:Cyclophosphamide; D010396:Penicillamine; D008727:Methotrexate